The Efficacy of Intravitreal Bevacizumab in Vitreous Hemorrhage of Diabetic Subjects

• Published in: Turk oftalmoloji gazetesi Vol. 46; no. 5; pp. 221 - 225
• Main Authors: Alagöz, Cengiz, Yıldırım, Yusuf, Kocamaz, Murat, Baz, Ökkeş, Çiçek, Uğur, Çelik, Burcu, Demirkale, Halil İbrahim, Yazıcı, Ahmet Taylan, Taşkapılı, Muhittin
• Format: Journal Article
• Language: English; Turkish
• Published: Turkey Galenos Yayinevi Tic. Ltd 01.10.2016; Galenos Publishing House; Galenos Publishing; Galenos Yayinevi
• Subjects: Diabetic retinopathy; Drug therapy; Health aspects; Hemorrhage; intravitreal bevacizumab; Original; Proliferative diabetic retinopathy; vitreous hemorrhage; Vitreous humor; intravitreal bevacizumab; Proliferative diabetic retinopathy; vitreous hemorrhage
• ISSN: 2149-8695; 1300-0659; 2149-8709; 2147-2661
• DOI: 10.4274/tjo.82542

To evaluate the efficacy of intravitreal bevacizumab (IVB) in the resolution of vitreous hemorrhage (VH) secondary to proliferative diabetic retinopathy (PDR). Seventy eyes of 70 patients (43 male, mean age 55.6±12.2 years) diagnosed with VH secondary to PDR were evaluated retrospectively. Demographic characteristics of the patients, baseline and final clinical results, and the interventions the patients were subject to were recorded. The patients who received IVB injections (group 1, n=29) were compared to those who did not receive injections (group 2, n=41) in terms of VH clearance time and surgery rates. The mean follow-up time was 14.5±6.1 months in group 1 and 18.4±9.6 months in group 2 (p=0.185). The mean visual acuity was similar between the groups at baseline and at the last visit (for all p>0.05). Panretinal photocoagulation could be applied in 86% of subjects in group 1 and in 58% in group 2 2 within the first month (p=0.016). VH clearance time was not different between the groups (2.3±2.1 months in group 1 and 3.4±2.6 months in group 2, p=0.146). The number of subjects requiring surgery was 7 (24%) in group 1 and 20 (48.8%) in group 2 (p=0.048). IVB was found effective in cases with VH secondary to PDR in terms of reducing the need for surgery and increasing the rate of subjects to whom panretinal photocoagulation could be applied in the early period, although there was no impact on final visual acuity.